 | • レポートコード：QFJ1-5497 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：新技術 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、血漿由来治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アルブミン、免疫グロブリン、第VIII因子、その他）、用途別市場規模（血友病、原発性免疫不全症（PID）、特発性血小板減少性紫斑病（ITP）、新型コロナウイルス感染症、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・血漿由来治療の市場動向 ・企業の競争状況、市場シェア ・血漿由来治療の種類別市場規模と予測2016-2027（アルブミン、免疫グロブリン、第VIII因子、その他） ・血漿由来治療の用途別市場規模と予測2016-2027（血友病、原発性免疫不全症（PID）、特発性血小板減少性紫斑病（ITP）、新型コロナウイルス感染症、その他） ・血漿由来治療の北米市場規模2016-2027（アメリカ、カナダ） ・血漿由来治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・血漿由来治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・血漿由来治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・血漿由来治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（CSL Behring LLC、Shire、Bayer、Kedrion、Takeda、Biotest、Octaparma、Bio Products Laboratory (BPL)、LFB、Grifols） ・結論 |
Plasma-derived therapeutics start from human blood plasma instead of the chemical or synthetic materials from which most pharmaceuticals are made.
In 2021, the global Plasma-derived Therapies market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global Plasma-derived Therapies status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Plasma-derived Therapies development in North America, Europe, Japan, China, Southeast Asia, India, etc.
Global Plasma-derived Therapies Scope and Market Size
Plasma-derived Therapies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Plasma-derived Therapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Albumin
Immunoglobulin
Factor VIII
Others
Segment by Application
Hemophilia
Primary Immunodeficiencies (PIDs)
Idiopathic Thrombocytopenic Purpura (ITP)
COVID-19
Others
By Region
North America
Europe
Japan
China
Southeast Asia
India
By Company
CSL Behring LLC
Shire
Bayer
Kedrion
Takeda
Biotest
Octaparma
Bio Products Laboratory (BPL)
LFB
Grifols
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasma-derived Therapies Market Size Growth Rate by Type (2021-2027)
1.2.2 Albumin
1.2.3 Immunoglobulin
1.2.4 Factor VIII
1.2.5 Others
1.3 Market by Application
1.3.1 Global Plasma-derived Therapies Market Share by Application (2021-2027)
1.3.2 Hemophilia
1.3.3 Primary Immunodeficiencies (PIDs)
1.3.4 Idiopathic Thrombocytopenic Purpura (ITP)
1.3.5 COVID-19
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Plasma-derived Therapies Market Size
2.2 Plasma-derived Therapies Market Size by Regions
2.2.1 Plasma-derived Therapies Growth Rate by Regions (2021-2027)
2.2.2 Plasma-derived Therapies Market Share by Regions (2021-2027)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 Plasma-derived Therapies Revenue by Players (2020-2021)
3.2 Plasma-derived Therapies Key Players Headquaters and Area Served
3.3 Key Players Plasma-derived Therapies Product/Solution/Service
3.4 Date of Enter into Plasma-derived Therapies Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global Plasma-derived Therapies Market Size by Type (2021-2027)
4.2 Global Plasma-derived Therapies Market Size by Application (2021-2027)
5 North America
5.1 North America Plasma-derived Therapies Market Forecast (2021-2027)
5.2 Plasma-derived Therapies Key Players in North America
5.3 North America Plasma-derived Therapies Market Size by Type
5.4 North America Plasma-derived Therapies Market Size by Application
6.4.4 Canada
6 Europe
6.1 Europe Plasma-derived Therapies Market Forecast (2021-2027)
6.2 Plasma-derived Therapies Key Players in Europe
6.3 Europe Plasma-derived Therapies Market Size by Type
6.4 Europe Plasma-derived Therapies Market Size by Application
7 Japan
7.1 Japan Plasma-derived Therapies Market Forecast (2021-2027)
7.2 Plasma-derived Therapies Key Players in Europe
7.3 Japan Plasma-derived Therapies Market Size by Type
7.4 Japan Plasma-derived Therapies Market Size by Application
8 Rest of World
8.1 China
8.1.1 China Plasma-derived Therapies Market Analysis
8.1.2 Key Players in China
8.2 Southeast Asia
8.2.1 Southeast Asia Plasma-derived Therapies Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India Plasma-derived Therapies Market Analysis
8.3.2 Key Players in India
9 International Player Profiles
9.1 CSL Behring LLC
9.1.1 CSL Behring LLC Company Details
9.1.2 CSL Behring LLC Description and Business Overview
9.1.3 CSL Behring LLC Plasma-derived Therapies Introduction
9.1.4 CSL Behring LLC Revenue in Plasma-derived Therapies Business (2020-2021)
9.1.5 CSL Behring LLC Recent Development
9.2 Shire
9.2.1 Shire Company Details
9.2.2 Shire Description and Business Overview
9.2.3 Shire Plasma-derived Therapies Introduction
9.2.4 Shire Revenue in Plasma-derived Therapies Business (2020-2021)
9.2.5 Shire Recent Development
9.3 Bayer
9.3.1 Bayer Company Details
9.3.2 Bayer Description and Business Overview
9.3.3 Bayer Plasma-derived Therapies Introduction
9.3.4 Bayer Revenue in Plasma-derived Therapies Business (2020-2021)
9.3.5 Bayer Recent Development
9.4 Kedrion
9.4.1 Kedrion Company Details
9.4.2 Kedrion Description and Business Overview
9.4.3 Kedrion Plasma-derived Therapies Introduction
9.4.4 Kedrion Revenue in Plasma-derived Therapies Business (2020-2021)
9.4.5 Kedrion Recent Development
9.5 Takeda
9.5.1 Takeda Company Details
9.5.2 Takeda Description and Business Overview
9.5.3 Takeda Plasma-derived Therapies Introduction
9.5.4 Takeda Revenue in Plasma-derived Therapies Business (2020-2021)
9.5.5 Takeda Recent Development
9.6 Biotest
9.6.1 Biotest Company Details
9.6.2 Biotest Description and Business Overview
9.6.3 Biotest Plasma-derived Therapies Introduction
9.6.4 Biotest Revenue in Plasma-derived Therapies Business (2020-2021)
9.6.5 Biotest Recent Development
9.7 Octaparma
9.7.1 Octaparma Company Details
9.7.2 Octaparma Description and Business Overview
9.7.3 Octaparma Plasma-derived Therapies Introduction
9.7.4 Octaparma Revenue in Plasma-derived Therapies Business (2020-2021)
9.7.5 Octaparma Recent Development
9.8 Bio Products Laboratory (BPL)
9.8.1 Bio Products Laboratory (BPL) Company Details
9.8.2 Bio Products Laboratory (BPL) Description and Business Overview
9.8.3 Bio Products Laboratory (BPL) Plasma-derived Therapies Introduction
9.8.4 Bio Products Laboratory (BPL) Revenue in Plasma-derived Therapies Business (2020-2021)
9.8.5 Bio Products Laboratory (BPL) Recent Development
9.9 LFB
9.9.1 LFB Company Details
9.9.2 LFB Description and Business Overview
9.9.3 LFB Plasma-derived Therapies Introduction
9.9.4 LFB Revenue in Plasma-derived Therapies Business (2020-2021)
9.9.5 LFB Recent Development
9.10 Grifols
9.10.1 Grifols Company Details
9.10.2 Grifols Description and Business Overview
9.10.3 Grifols Plasma-derived Therapies Introduction
9.10.4 Grifols Revenue in Plasma-derived Therapies Business (2020-2021)
9.10.5 Grifols Recent Development
10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
Table 1. Global Plasma-derived Therapies Market Size Growth Rate by Type (2021-2027) (US$ Million)
Table 2. Key Players of Albumin
Table 3. Key Players of Immunoglobulin
Table 4. Key Players of Factor VIII
Table 5. Key Players of Others
Table 6. Global Plasma-derived Therapies Market Size Growth by Application (2021-2027) (US$ Million)
Table 7. Global Plasma-derived Therapies Market Size by Regions (2021-2027) (US$ Million)
Table 8. Global Plasma-derived Therapies Market Share by Regions (2021-2027)
Table 9. Market Top Trends
Table 10. Market Use Cases
Table 11. Global Plasma-derived Therapies Revenue by Players (2020-2021) (US$ Million)
Table 12. Global Plasma-derived Therapies Market Share by Players (2020-2021)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players Plasma-derived Therapies Product Solution and Service
Table 15. Date of Enter into Plasma-derived Therapies Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global Plasma-derived Therapies Market Size by Type (2021-2027) (US$ Million)
Table 18. Global Plasma-derived Therapies Market Size Share by Type (2021-2027)
Table 19. Global Plasma-derived Therapies Market Size by Application (2021-2027) (US$ Million)
Table 20. Global Plasma-derived Therapies Market Size Share by Application (2021-2027)
Table 21. North America Key Players Plasma-derived Therapies Revenue (2020-2021) (US$ Million)
Table 22. North America Key Players Plasma-derived Therapies Market Share (2020-2021)
Table 23. North America Plasma-derived Therapies Market Size by Type (2021-2027) (US$ Million)
Table 24. North America Plasma-derived Therapies Market Share by Type (2021-2027)
Table 25. North America Plasma-derived Therapies Market Size by Application (2021-2027) (US$ Million)
Table 26. North America Plasma-derived Therapies Market Share by Application (2021-2027)
Table 27. Europe Key Players Plasma-derived Therapies Revenue (2020-2021) (US$ Million)
Table 28. Europe Key Players Plasma-derived Therapies Market Share (2020-2021)
Table 29. Europe Plasma-derived Therapies Market Size by Type (2021-2027) (US$ Million)
Table 30. Europe Plasma-derived Therapies Market Share by Type (2021-2027)
Table 31. Europe Plasma-derived Therapies Market Size by Application (2021-2027) (US$ Million)
Table 32. Europe Plasma-derived Therapies Market Share by Application (2021-2027)
Table 33. Japan Key Players Plasma-derived Therapies Revenue (2020-2021) (US$ Million)
Table 34. Japan Key Players Plasma-derived Therapies Market Share (2020-2021)
Table 35. Japan Plasma-derived Therapies Market Size by Type (2021-2027) (US$ Million)
Table 36. Japan Plasma-derived Therapies Market Share by Type (2021-2027)
Table 37. Japan Plasma-derived Therapies Market Size by Application (2021-2027) (US$ Million)
Table 38. Japan Plasma-derived Therapies Market Share by Application (2021-2027)
Table 39. Key Players in China
Table 40. Key Players in Southeast Asia
Table 41. Key Players in India
Table 42. CSL Behring LLC Company Details
Table 43. CSL Behring LLC Description and Business Overview
Table 44. CSL Behring LLC Plasma-derived Therapies Product
Table 45. CSL Behring LLC Revenue in Plasma-derived Therapies Business 2020 and 2021
Table 46. CSL Behring LLC Recent Development
Table 47. Shire Company Details
Table 48. Shire Description and Business Overview
Table 49. Shire Plasma-derived Therapies Product
Table 50. Shire Revenue in Plasma-derived Therapies Business 2020 and 2021
Table 51. Shire Recent Development
Table 52. Bayer Company Details
Table 53. Bayer Description and Business Overview
Table 54. Bayer Plasma-derived Therapies Product
Table 55. Bayer Revenue in Plasma-derived Therapies Business 2020 and 2021
Table 56. Bayer Recent Development
Table 57. Kedrion Company Details
Table 58. Kedrion Description and Business Overview
Table 59. Kedrion Plasma-derived Therapies Product
Table 60. Kedrion Revenue in Plasma-derived Therapies Business 2020 and 2021
Table 61. Kedrion Recent Development
Table 62. Takeda Company Details
Table 63. Takeda Description and Business Overview
Table 64. Takeda Plasma-derived Therapies Product
Table 65. Takeda Revenue in Plasma-derived Therapies Business 2020 and 2021
Table 66. Takeda Recent Development
Table 67. Biotest Company Details
Table 68. Biotest Description and Business Overview
Table 69. Biotest Plasma-derived Therapies Product
Table 70. Biotest Revenue in Plasma-derived Therapies Business 2020 and 2021
Table 71. Biotest Recent Development
Table 72. Octaparma Company Details
Table 73. Octaparma Description and Business Overview
Table 74. Octaparma Plasma-derived Therapies Product
Table 75. Octaparma Revenue in Plasma-derived Therapies Business 2020 and 2021
Table 76. Octaparma Recent Development
Table 77. Bio Products Laboratory (BPL) Company Details
Table 78. Bio Products Laboratory (BPL) Description and Business Overview
Table 79. Bio Products Laboratory (BPL) Plasma-derived Therapies Product
Table 80. Bio Products Laboratory (BPL) Revenue in Plasma-derived Therapies Business 2020 and 2021
Table 81. Bio Products Laboratory (BPL) Recent Development
Table 82. LFB Company Details
Table 83. LFB Description and Business Overview
Table 84. LFB Plasma-derived Therapies Product
Table 85. LFB Revenue in Plasma-derived Therapies Business 2020 and 2021
Table 86. LFB Recent Development
Table 87. Grifols Company Details
Table 88. Grifols Description and Business Overview
Table 89. Grifols Plasma-derived Therapies Product
Table 90. Grifols Revenue in Plasma-derived Therapies Business 2020 and 2021
Table 91. Grifols Recent Development
Table 92. Plasma-derived Therapies Market Trends
Table 93. Plasma-derived Therapies Market Drivers
Table 94. Plasma-derived Therapies Market Challenges
Table 95. Plasma-derived Therapies Market Restraints
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plasma-derived Therapies Market Share by Type in 2021 & 2027
Figure 2. Albumin Features
Figure 3. Immunoglobulin Features
Figure 4. Factor VIII Features
Figure 5. Others Features
Figure 6. Global Plasma-derived Therapies Market Share by Application in 2021 & 2027
Figure 7. Hemophilia Case Studies
Figure 8. Primary Immunodeficiencies (PIDs) Case Studies
Figure 9. Idiopathic Thrombocytopenic Purpura (ITP) Case Studies
Figure 10. COVID-19 Case Studies
Figure 11. Others Case Studies
Figure 12. Plasma-derived Therapies Report Years Considered
Figure 13. Global Plasma-derived Therapies Market Size and Growth Rate (2020-2027) (US$ Million)
Figure 14. Global Plasma-derived Therapies Market Share by Regions (2020-2027)
Figure 15. Global Plasma-derived Therapies Market Share by Players in 2021
Figure 16. Global Plasma-derived Therapies Market Size Market Share by Type (2021-2027)
Figure 17. Global Plasma-derived Therapies Market Size Market Share by Application (2021-2027)
Figure 18. Global Plasma-derived Therapies Revenue Market Share by Application in 2021
Figure 19. North America Plasma-derived Therapies Market Size 2021-2027 (US$ Million)
Figure 20. Europe Plasma-derived Therapies Market Size 2021-2027 (US$ Million)
Figure 21. Japan Plasma-derived Therapies Market Size 2021-2027 (US$ Million)
Figure 22. Plasma-derived Therapies Market Size in China (2021-2027) (US$ Million)
Figure 23. Plasma-derived Therapies Market Size in Southeast Asia (2021-2027) (US$ Million)
Figure 24. Plasma-derived Therapies Market Size in India (2021-2027) (US$ Million)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
世界の血漿由来人血清アルブミン検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Plasma-derived Human Serum Albumin Test Market The global Plasma-derived Human Serum Albumin Test market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis…- ヒト血漿由来治療薬のグローバル市場調査 2019年 The global Human Plasma-Derived Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Human Plasma-Derived Therapeutics volume and value at global level, regional level and company level. Fro…
- 世界のグリア細胞株由来神経栄養因子市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Glial Cell Line Derived Neurotrophic Factor Market The global Glial Cell Line Derived Neurotrophic Factor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in …
- 世界の脱毛症幹細胞＆多血小板血漿（PRP）治療市場規模・現状・予測（2021年-2027年） Platelet-rich plasma (PRP) has emerged as a new treatment modality in regenerative plastic surgery, and preliminary evidence suggests that it might have a beneficial role in hair regrowth. Market Analysis and Insights: Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market The gl…
- ヒト血液凝固因子VIIIのグローバル市場2021 Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. North America is the largest consumption market of Human Coagulation Factor VIII, with sal…